The Centers for Medicare and Medicaid Services has announced a new proposal to reduce payment rates for drugs dispensed under the 340B Drug Pricing Program, marking another regulatory intervention in a scheme that has become increasingly controversial. The 340B program, established in 1992, was designed to enable safety-net hospitals and eligible healthcare entities to purchase outpatient medications at substantial discounts below average wholesale prices. However, mounting scrutiny from policymakers and patient advocacy groups has raised questions about whether the savings genuinely benefit patients or primarily enhance hospital revenues. Medicare’s latest cost-containment initiative reflects growing federal concern over program spending and accountability. Healthcare administrators and policy experts are closely monitoring the proposal’s potential impact on hospital finances and patient access to medications. Read the full article on GMJ Newsroom.
Was this article helpful?
GMJ Brief · Announcement
📰 Read the full article: Medicare Proposes Fresh Cuts to Hospital 340B Drug Discount Program →
